Skip to main content
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery 1/2017

03.01.2017 | Original Article

Assessment of treatment response in patients with laryngopharyngeal reflux

verfasst von: Anagha Atul Joshi, Bhagyashri Ganesh Chiplunkar, Renuka Anil Bradoo

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

To evaluate treatment response in patients with laryngopharyngeal reflux (LPR). A prospective study of 100 patients with voice disorders was conducted. Patients were evaluated using reflux symptom index (RSI) and reflux finding score (RFS) by 70° rigid laryngoscope. Patients with RFS score of 7 or more were diagnosed of having LPR and were started with anti-reflux therapy for a period of 6 months. Patients were assessed at regular intervals using RSI and RFS. The prevalence of LPR in patients with voice disorders was found to be 25%. The mean RSI score improved gradually and significantly over a period of 6 months from 11.84 at presentation to 2.04 after 6 months of treatment (p value <0.001). The mean value of RFS improved from 7.92 at entry to 1.52 after 6 months of treatment (p value <0.001). However, it was found that the improvement was not significant at end of first month of treatment, and improvement in RSI and RFS scores was found only after 2 months of treatment. RSI and RFS improve significantly after treatment for 6 months with PPI like Omeprazole. But the improvement starts from the 2nd month from the onset of treatment. Treatment of LPR for at least 6 months may be indicated to attain a full resolution of physical findings.
Literatur
1.
Zurück zum Zitat Vaezi MF (2003) Extraesophageal manifestations of gastroesophageal reflux disease. Clin Cornerstone 5:32–38CrossRefPubMed Vaezi MF (2003) Extraesophageal manifestations of gastroesophageal reflux disease. Clin Cornerstone 5:32–38CrossRefPubMed
2.
Zurück zum Zitat Park W, Hicks DM, Khandwala F et al (2005) Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope 115:1230–1238CrossRefPubMed Park W, Hicks DM, Khandwala F et al (2005) Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope 115:1230–1238CrossRefPubMed
3.
Zurück zum Zitat Belafsky PC, Postma GN, Koufman JA (2001) The validity and reliability of the reflux finding score (RFS). Laryngoscope 111(8):1313–1317CrossRefPubMed Belafsky PC, Postma GN, Koufman JA (2001) The validity and reliability of the reflux finding score (RFS). Laryngoscope 111(8):1313–1317CrossRefPubMed
4.
Zurück zum Zitat Katz PO, Castell DO (2000) Medical therapy of supra- esophageal gastroesophageal reflux disease. Am J Med 108(suppl 4a):170S–177SCrossRefPubMed Katz PO, Castell DO (2000) Medical therapy of supra- esophageal gastroesophageal reflux disease. Am J Med 108(suppl 4a):170S–177SCrossRefPubMed
5.
Zurück zum Zitat Steward DL, Wilson KM, Kelly DH et al (2004) Proton pump inhibitor therapy for chronic laryngopharyngitis: a randomized placebo-control trial. Otolaryngol Head Neck Surg 131:342–350CrossRefPubMed Steward DL, Wilson KM, Kelly DH et al (2004) Proton pump inhibitor therapy for chronic laryngopharyngitis: a randomized placebo-control trial. Otolaryngol Head Neck Surg 131:342–350CrossRefPubMed
6.
Zurück zum Zitat Habermann W, Schmid C, Neumann K, Devaney T, Hammer HF (2012) Reflux symptom index and reflux finding score in otolaryngologic practice. J Voice 26(3):e123–e127CrossRefPubMed Habermann W, Schmid C, Neumann K, Devaney T, Hammer HF (2012) Reflux symptom index and reflux finding score in otolaryngologic practice. J Voice 26(3):e123–e127CrossRefPubMed
7.
Zurück zum Zitat Rouev P, Chakarski I, Doskov D, Dimov G, Staykova E (2005) Laryngopharyngeal symptoms and gastroesophageal reflux disease. J Voice 19(3):476–480CrossRefPubMed Rouev P, Chakarski I, Doskov D, Dimov G, Staykova E (2005) Laryngopharyngeal symptoms and gastroesophageal reflux disease. J Voice 19(3):476–480CrossRefPubMed
8.
Zurück zum Zitat Belafsky PC, Postma GN, Koufman JA (2001) Laryngopharyngeal reflux symptoms improve before changes in physical findings. Laryngoscope 111(6):979–981CrossRefPubMed Belafsky PC, Postma GN, Koufman JA (2001) Laryngopharyngeal reflux symptoms improve before changes in physical findings. Laryngoscope 111(6):979–981CrossRefPubMed
9.
Zurück zum Zitat Koufman J, Sataloff RT, Toohill R (1996) Laryngopharyngeal reflux: consensus conference report. J Voice 10(3):215–216CrossRefPubMed Koufman J, Sataloff RT, Toohill R (1996) Laryngopharyngeal reflux: consensus conference report. J Voice 10(3):215–216CrossRefPubMed
10.
Zurück zum Zitat Noordzij JP, Khidr A, Evans BA, Desper E, Mittal RK, Reibel JF et al (2001) Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 111(12):2147–2151CrossRefPubMed Noordzij JP, Khidr A, Evans BA, Desper E, Mittal RK, Reibel JF et al (2001) Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 111(12):2147–2151CrossRefPubMed
Metadaten
Titel
Assessment of treatment response in patients with laryngopharyngeal reflux
verfasst von
Anagha Atul Joshi
Bhagyashri Ganesh Chiplunkar
Renuka Anil Bradoo
Publikationsdatum
03.01.2017
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe 1/2017
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-016-1046-5

Weitere Artikel der Ausgabe 1/2017

Indian Journal of Otolaryngology and Head & Neck Surgery 1/2017 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.